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INTRODUCTION TO THE HUMAN GUT MICROBIOTA AND  
ITS EFFECT IN WEIGHT REGULATION 
 
ERIC M. GAVARRE 
 
 
 
 
ABSTRACT 
 
 There has been a rapid increase in the number of overweight and obese 
individuals worldwide in the past 50 years. It has been assumed that an increased caloric 
intake and a more sedentary lifestyle are the main causes of this rise. However, recent 
evidence has shown that the microbes that live in the human gastrointestinal tract may 
play a role in the regulation of weight and obesity development. These microbes, termed 
the gut microbiota, are commensal and symbiotic microbes that are densely populated 
throughout an individual’s gastrointestinal tract. This paper presents the relevant research 
and possible mechanisms of how these microbes, mainly bacteria, are thought to play a 
role in weight regulation and obesity. 
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INTRODUCTION 
 
There has been a rapid increase in the number of obese and overweight 
individuals worldwide in the past 50 years. It is estimated that obesity has doubled since 
1980 (“WHO | Obesity and overweight,” 2013). Due to this rapid increase, there has been 
an increase in studies on this topic recently. Some researchers hypothesize that the 
primary cause is due to two factors: increased caloric intake and an increased sedentary 
lifestyle causing an energy imbalance between calories consumed and calories expended 
(Cani & Delzenne, 2011; Zhao, 2013). However, recent research has shown that the 
multitudes of microorganisms that reside in the human gastrointestinal tract, the human 
microbiota, may have a role in weight regulation and the development of obesity (Shen, 
Obin, & Zhao, 2013; Turnbaugh et al., 2006). Although the mechanism of how the 
microbiota accomplishes this task is still being elucidated, there is strong evidence 
indicating that the human gut microbiota plays a role in weight regulation and 
development of obesity.  
The World Health Organization (WHO) defines “overweight” and “obesity” as an 
unusual or excessive accretion of fat and triglycerides which may impair an individual’s 
health (“WHO | Obesity and overweight,” 2013). Obesity can include many different 
disease phenotypes such as fatty liver, hypertension, insulin resistance and the 
accumulation of abdominal adipose tissue that is associated with a low grade systemic 
and chronic inflammation  (Cani & Delzenne, 2011; Shen et al., 2013). It raises an 
individual’s chance of having type II diabetes mellitus, cardiovascular disease, and 
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osteoarthritis as well as increasing the chances of certain cancers such as endometrial, 
breast and colon. The World Health Organization estimates that the number of 
overweight adults aged 20 years and older surpassed 1.4 billion in 2008. Of that number, 
200 million men and 300 million women were obese. Childhood obesity is also 
increasing with approximately 40 million children aged 5 or younger who are 
overweight. This is especially harmful to children as it leads to complications such as 
breathing difficulties, hypertension, early markers of cardiovascular disease and 
psychological stress (“Obesity and Overweight for Professionals: Data and Statistics: 
Adult Obesity - DNPAO - CDC,” 2013). 
The prevalence of obesity not only impacts an individual’s health, but it also has 
negative economic influences on an individual and the health care system. The Centers 
for Disease Control and Prevention (CDC) estimates that in the US, the estimated annual 
medical cost of obesity was $147 billion dollars in 2008. An obese person had average 
medical costs that were $1,429 more than a normal weight individual in previous years 
(“Obesity and Overweight for Professionals: Data and Statistics: Adult Obesity - DNPAO 
- CDC,” 2013). In the United States, obesity is a major health problem. In 2009, the CDC 
found that 35.7% of the US population aged 20 and over were obese (Figure 1) (CDC, 
2012). In the recent past there has been a perception that obesity is a disease that is 
mainly prevalent in high income countries. However, the percentage of individuals who 
are overweight or obese in low and middle income countries is now rising (Zhao, 2013). 
Of the 40 million children who were overweight in 2011, 30 million lived in developing 
countries versus the estimated 10 million overweight children in developed countries 
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(“WHO | Obesity and overweight,” 2013).  Until recently, the United States had the 
highest percentage of obese individuals since researchers began studying this epidemic. 
However, in 2013 the Food and Agriculture Organization of the United Nations reported 
that Mexico surpassed the United States in having a higher percentage of obese 
individuals, 32.8%, as compared with the United States, 31.8% (Food and Agriculture 
Organization of the UN, 2013). This report further demonstrates that obesity has become 
a worldwide problem, and not just a problem that high income countries must try to 
combat.  Being obese or overweight is now the 5
th
 leading cause of death throughout the 
world. In fact, being overweight or obese is associated with more deaths throughout the 
world than being underweight. Sixty five percent of the world’s population live in a 
country where more people die from complications of being overweight or obese than 
from hunger or starvation (“WHO | Obesity and Overweight,” 2013). 
  
 4 
 
 
Figure 1. Prevalence of Obesity in the United States 2009-2010. (Centers for Disease 
Control and Prevention, 2012) 
 
The Gut Microbiota 
 The gut microbiota is defined as the community of microbes that reside in an 
individual’s gastrointestinal tract (GI tract) (Gordon, 2012). This term incorporates 
microbes from all three domains: Archaea, Eukaryota and Bacteria. It also includes the 
viruses associated with each domain (Gordon, 2012). These are commensal and 
symbiotic microbes and the majority of them are bacteria (Shen et al., 2013). During the 
past 10 years, there has been an increased interest in the role that the human microbiota 
plays in human health due to advances in technology that have enabled researchers to 
investigate these intricate communities. The human microbiota includes microbes that 
live in the human gut as well as the microbes that exist elsewhere in the human body such 
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as in the oral cavity, nostrils and skin (Figure 2). The type of microbes in each of these 
sites depends primarily on where the microbes are located anatomically. Interestingly, 
there is marked variation, and some similarities, in composition of these communities 
between individuals. Researchers conservatively estimate that microbes have been living 
and performing metabolic and other functions within animals for the past 500 million 
years. During those years, these microbes have undergone a specific selection based on 
co-adaptation (Cho & Blaser, 2012).  
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Figure 2. Compositional differences in the Microbiome by Anatomical site. (Cho & 
Blaser, 2012) 
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In humans, the colon is the most densely colonized anatomical area and contains 
the most diverse populations of bacteria compared to other places in the body (Zhao, 
2013). Some of the many functions of the gut microbiota include: nutrient and drug 
metabolism, epithelial cell proliferation, immune system and barrier function against 
enteric pathogens and the synthesis and bioavailability of several vitamins (Cani & 
Delzenne, 2009). Enzymes that are produced by these microbes enable the host to process 
compounds that would have otherwise passed through the host unaltered. It has been 
estimated that the short chain fatty acids that are produced after fermentation of dietary 
fibers account for 10% of the total dietary energy supply in humans ( Duncan et al., 
2008). In fact, most gut microbes are either harmless or are of benefit to the host 
(Lozupone, Stombaugh, Gordon, Jansson, & Knight, 2012).  
One effect of having numerous bacteria reside within the colon is that some of 
their metabolites enter the blood stream. In fact, one third of all small molecules found in 
human blood can be traced to bacteria in the gut microbiota.  Some of the metabolites 
have a beneficial effect to the human host. Effects of these metabolites include: anti-
inflammatory properties, anti-oxidant properties, pain relief activity, a source of energy, a 
source of vitamins and gut barrier function control. For example, butyrate, a short chain 
fatty acid (SCFA), is produced by bacterial fermentation of dietary fibers. It has been 
shown that this SCFA could then act as a source of energy for human colonocytes as well 
as having many other effects such as: increasing satiety, alleviating  inflammation, 
reducing carcinogenesis in the colon, mitigating oxidative stress and improving gut 
barrier function (Zhao, 2013). 
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However, there are bacterial-derived products that are harmful. Cytotoxins, 
genotoxins and immunotoxins are all examples of bacterial exotoxins or metabolites that 
have deleterious effects on the human host. Lipopolysaccharide (LPS) is one example of 
a damaging cell wall component released by Gram-negative bacteria either by release of 
cell wall “bleb” or by cell lysis (Zhao, 2013). It has been shown that lipopolysaccharide, 
when injected subcutaneously, can provoke an inflammatory response as well as 
aggravate chronic inflammation that is seen in conditions such as obesity and insulin 
resistance (Cani et al., 2007). 
There are approximately 1.5 kilograms of bacteria that dwell in the human colon. 
Those trillions of cells help to breakdown otherwise indigestible food (Ley, Turnbaugh, 
Klein, & Gordon, 2006).  New technologies for studying the microbiota, such as 16s 
rRNA sequencing and shotgun high throughput sequencing, have led to findings that alter 
how researchers and scientists consider bacteria that live inside humans. Human beings 
are now being considered supraorganisms that are composed of both human and 
microbial cells (Zhao, 2013). It is estimated that human beings are composed of 10% 
human cells and 90% prokaryotic cells (Lederberg, 2000). These prokaryotic cells not 
only add a wide array of different cells to a host, but also add a tremendous amount of 
genetic material to that host. The human genome contains approximately 23,000 genes, 
but the genes that are associated with the gut microbiota, termed the gut microbiome, 
exceed 3 million, i.e. more than 130-fold more bacterial genes than human genes 
(Shanahan, Dinan, Ross, & Hill, 2012; Zhao, 2013). The aggregate of the microbiome 
and the human genome is termed the metabolome (Wall et al., 2009). These recent 
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findings are relevant to medicine because all genes present in the body have the potential 
to affect human health, either positively or negatively (McNulty et al., 2013). Therefore, 
because the metabolome consists of mainly genes from these microbes, it can be said that 
human beings only genetically inherit 1% of the genes that reside in cells in their body. 
The rest are acquired from the immediate environment breast milk, contact with other 
people, as well as other sources (Zhao, 2013). 
 
 
Figure 3. Human beings as supraorganisms. Humans consist of both human cells and 
microbial cells. The gut microbiota interacts with host genetics and the environment to 
influence health of the host (Zhao, 2013) 
 
There are more than 1000 phylotypes of bacteria in the gut microbiota. A 
phylotype can be described as collections of 16S rRNA sequences which have 97-99% 
similar identities organized into the same operational taxonomic unit symbolizing one 
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species level sequence or “phylotype”. These phylotypes are usually identified by using 
shotgun high-throughput sequencing or 16s rRNA sequencing (Shen et al., 2013). There 
are 6 divisions of bacteria present in the gut microbiota: Proteobacteria, Actinobacteria, 
Fusobacteria, Verrucomicrobia, Firmicutes and Bacteroidetes. However, about 90% of 
the bacteria belong to either the Firmicutes or Bacteroidetes (Cho & Blaser, 2012; 
McNulty et al., 2013). Other microbes that are present are Methanogenic Archaea, 
eukaryotes (mainly yeasts) and viruses (mainly phages). In the investigation to find 
bacterial species which represent a “a core microbiota”, a few species have been 
identified as notable members in the human colon: Faecalibacterium prausnitii, 
Roseburia intestinalis and Bacteroides uniformis (Lozupone et al., 2012).  
Although these six divisions are consistently the main components of the gut 
microbiota, the proportions of species and phyla as well as the specific species that are 
present, vary across individuals (Song et al., 2013). Cultured-based studies have indicated 
that healthy individuals share many of the same bacteria in their colon, termed the “core 
microbiota”. However, culture-independent sequencing studies contradict this concept. 
Other studies have shown that species within the gut microbiota vary over time and 
across geographic populations (Lozupone et al., 2012). Interestingly, although these 
populations differ in the composition of the gut microbiota, the functional gene profiles 
remain quite similar (Turnbaugh et al., 2009). Jumpertz et al conducted studies that 
showed individual variability of bacterial composition in fecal matter. Researchers 
collected stool samples of subjects at various time points after being placed on certain 
diets. Samples taken from the same subject in their study were more similar, irrespective 
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of current diet, than when compared to samples taken from different subjects. This 
reinforces the notion of individual variability in the gut microbiota (Jumpertz et al., 
2011). 
Variation in the Gut Microbiota 
After the initial realization that the gut microbiota may have a role in weight 
regulation and the development of obesity, researchers sought out to learn more about the 
details of these many microbes inhabiting not only the human colon but also throughout 
the body. It was found that the composition of the microbiota varied by anatomical site. 
They also found that interpersonal variation is extensive, and is surprisingly more 
variable than temporal variation seen in individuals (Cho & Blaser, 2012) (Figure 4). 
Researchers are currently investing what factors drive this variation.  
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Figure 4. Diversity of the human microbiota at different phylogenetic scales. 
Variation in the gut microbiota between 4 individuals: A, B, C and D. The graph depicts 
variation seen at the phylum level. One difference is that individual A has a high 
proportion of Bacteroidetes where as individual D has a high proportion of Firmicutes. 
The tree depicts the phylogenetic relationships between species level phylotypes in the 
Firmicutes in individuals B and C. Red branches are specific to individual B, blue 
branches are specific to individual C and purple branches are shared. This tree 
demonstrates that although it may seem like there is less variation between individuals B 
and C at the phylum level, there is great variation seen at lower taxonomic levels.  
(Lozupone et al., 2012)   
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One major factor that drives changes in the composition of the human gut 
microbiota is diet. As will be mentioned later, it has been shown that the composition of 
bacteria in obese individuals can be modified by consuming a fat-restricted diet or a 
carbohydrate restricted-diet (Ley et al., 2006). 
The environment is also an important factor that has been shown to affect the 
constitution of the gut microbiota. This includes the environment in which a baby was 
born as well as the environment to which the human child is later exposed. For instance, 
there is increasingly more evidence for the transfer of the microbiota from the mother to 
the infant during the first months of the infant’s life. Prior to the rupture of the amniotic 
sac, the fetus is essentially sterile. However, during vaginal delivery, the first bacteria 
colonies in the infant resemble those from the mother’s vaginal canal as well as those 
present in the mother’s breast milk. Lactobacilli predominate in these colonies. 
Consistently, it was observed that this genus of bacteria flourishes in the infant’s 
gastrointestinal track at first. Lactobacilli is the pioneer population of bacteria in the 
colon and could possibly be responsible for preparing the colon for subsequent 
populations of colonizing microbes (Cho & Blaser, 2012). This preparation leads to many 
changes in the microbiota that occur throughout a person’s life. The microbiota in infants 
is very unstable and there are marked changes that occur early in life until a more 
established community is formed (Lozupone et al., 2012).  
A genetic component is also being investigated as a possible factor that helps to 
drive the variation seen in the microbiota. Two separate experiments showed that the 
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microbiota is more similar in twins and between a mother and a daughter than unrelated 
individuals (Dicksved et al., 2008; Turnbaugh et al., 2009).  These findings suggest that 
there is a genetic factor that partially determines the composition of the gut microbiota. 
Possible examples of a genetic component that is responsible for influencing composition 
of the gut microbiota include: host digestive physiology, pH of the gut, presence of bile 
acids as well as components of the innate immune system (Sylvia H. Duncan & Flint, 
2013; McNulty et al., 2013; Vijay-Kumar et al., 2010).  
Another example of how the environment and genetics both could affect the 
composition of the microbiota is seen when studying the microbiota from populations 
across the world. The microbiota from Italian children was seen to be vastly different 
from the microbiota present in children from rural Africa (Filippo et al., 2010). 
Furthermore, the gut microbiota found in children and adults in the US drastically varied 
from the gut microbiota found in populations from Malawi and Venezuela (Yatsunenko 
et al., 2012). It is difficult to determine what caused the variations in these examples for 
many different reasons. For example, not only are there genetic differences between the 
populations, these populations also differ in environmental exposure, sanitation levels, 
diet and antibiotic use (Lozupone et al., 2012). However, these two studies indicate that 
the environment, diet and genetics may all play a factor in determining the composition 
of the gut microbiota.  
Although the composition of the gut microbiota undergoes temporary and minor 
perturbations, in response to things such as a change in diet, it can also undergo a major 
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perturbation due to an enteric infection or the use of antibiotics. The effects of either of 
these could lead to a new steady state composition of the gut (Cho & Blaser, 2012).  
Why Study the Gut Microbiota? 
It is important to study the composition of the gut microbiota and to identify the 
factors that drive change within it because many disorders in human health such as 
obesity, malnutrition, inflammatory bowel disease and certain neurological disorders 
have been associated with disturbances in the normal state of the gut microbiota. 
However, it is also important to note that identifying the composition of the gut 
microbiota alone will not guide researchers to an understanding of how the gut 
microbiota is established and maintained or the mechanisms of its effects on health and 
disease. This in combination with sequencing community DNA, studying cultured 
isolates that have well characterized genome content and ex-vivo phenotypes together 
will provide the most information about the functions of the gut microbiota (Lozupone et 
al., 2012).  
The gut microbiota has gained attention in the past 10 years due to a possible link 
to weight regulation and the development of obesity in mice as well as humans. This was 
first observed when researchers found a difference in the ratio between two phyla in 
obese and non-obese individuals. This dysbiosis, whether at the level of the phylum or 
more specific taxon level, was hypothesized to aid in the development of obesity through 
weight regulation. The research presented in this thesis describes findings related to this 
hypothesis. This research, along with future research, is critical to human health as it 
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attempts to expand on an area of the human system that has not been previously studied. 
It will enable future clinicians and the general public the ability to monitor and possibly 
manipulate the gut microbiota in order to achieve better health.  
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PRESENTATION OF PUBLISHED DATA 
 
 Animals that are reared under sterile or germ-free conditions are classified as 
gnotobiotic (Gordon, 2012). They have been valuable to the study of the gut microbiota 
because they are able to provide an in-vivo model of the human gut microbiota when they 
are colonized with a defined population of sequenced human gut microbes. This provides 
researchers the opportunity to study microbes in ways that are not possible during human 
studies by tightly controlling experimental variables (McNulty et al., 2013). Germ free 
(GF) mice are defined as mice that do not have microorganisms living in or on them. 
These mice have been valuable to the gut microbiota investigations because they allow 
for the gut microbiota to be transplanted from a conventional mouse to a GF mouse. This 
process is termed conventionalization (Zhao, 2013). Researchers have relied on studying 
the microbiota that is located in the caecum because it is an anatomically distinct 
structure found at the distal small intestine and the proximal portion of the colon. There 
are a sufficient amount of microbes residing in the caecum which allow researchers to 
perform a metagenomic analyses on these microbes (Turnbaugh et al., 2006).  
 The seminal study about the role that the gut microbiota plays within host 
metabolism was first performed by Bäckhed and colleagues in 2004. They made the 
observation that GF C57BL/6 mice contained 42% less body fat than conventionally 
raised mice (CONV-R), which harbored a microbiota beginning at birth. Additionally, 
researchers observed that the epididymal fat pad weights were 47% greater in the CONV-
R animals. These characteristics were apparent even though the CONV-R mice consumed 
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29% less standard rodent chow diet than the GF mice. The GF mice were maintained 
under gnotobiotic isolators, kept on a strict 12 hour light schedule, and fed an autoclaved 
diet. They were purchased from a separate laboratory. Researchers determined the 
amount of body fat using dual energy x-ray absorptiometry. They then transplanted the 
gut microbiota from the cecum of CONV-R mouse into GF mice. CONV-R mice were 
fed a low-fat, polysaccharide diet and were maintained in a specified pathogen-free state 
prior to the conventionalization. The conventionalized mice were then placed in 
gnotobiotic isolator for 10-28 days under the same conditions as the GF mice. Total body 
fat content was measured five minutes after the mice were anesthetized with an 
intraperitoneal injection of ketamine and xylazine. The amount of normal standard rodent 
chow was measured in grams day. Three different conventionalizations were performed: 
a 10 day conventionalization, 14 day conventionalization and a 28 day 
conventionalization. They found that after a 14 day conventionalization, mice had a 57% 
total body fat content increase and a 61% increase in epididymal fat weight. This increase 
in total body fat was associated with a 7% decrease in lean body mass. A similar increase 
in total body fat was seen after a 10 day conventionalization and the 28 day 
conventionalization did not produce further increases in total body fat content nor 
epididymal fat pad weight. The increases in fat content were seen in the 14 day 
conventionalization despite the conventionalized mice consuming 27% less standard 
rodent chow than GF mice (Figure 5). It is important to note that these effects were not 
unique to one sex or the other. Also, the increases in fat were also seen in the NMRI 
inbred strain of GF mouse (90% increase in total body fat content with a 31% decrease in 
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rodent chow consumption) (Bäckhed et al., 2004). These findings led to many studies 
attempting to explain how the gut microbiota was able to affect the weight of mice and 
the possible mechanisms behind this process.  
 
 
Figure 5. Changes seen between GF, conventionalized and conventionally raised 
mice. Graph A depicts differences in total body fat percentage between the 3 groups. 
Graph B depicts the differences in Epididymal fat weight (g). (Bäckhed et al., 2004) 
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 In 2005, Ley and colleagues wanted to expand on the idea that the gut microbiota 
has an effect on obesity and the development of obesity. They sequenced 5,088 bacterial 
16s rRNA sequences from the microbiota located in the caecum of genetically obese 
mice (ob/ob), lean mice (ob/+), wild type siblings and their (ob/+) mothers. These mice 
were all fed the same polysaccharide-rich diet. Their results indicated that when 
compared to lean mice and their siblings, regardless of kinship, ob/ob mice had a 50% 
decrease in the amount of Bacteroidetes as well as a proportional increase in the amount 
of Firmicutes. These differences were seen throughout the phylum and not due to 
differences in food consumption (Ley et al., 2005).  
Turnbaugh and colleagues sought to examine if obesity is associated with changes 
in these two phyla, the Firmicutes and Bacteroidetes. They investigated the distal gut 
microbiomes of ob/ob, ob/+ and +/+ littermates through random shotgun sequencing of 
their caecal microbial DNA. The ob/ob mouse was used in this experiment because the 
researchers knew that these mice were obese due to increased food intake because of a 
leptin deficiency. The lean mice (ob/+ and +/+) mice were used as a comparison to the 
ob/ob mice. The researchers quantified the amount of short-chain fatty acids (SCFA’s) in 
the caecal microbiota of 4 lean and 5 obese conventionally raised C57BL/6J mice via gas 
chromatography mass-spectrometry quantification. The results showed that their caecum 
had an increased concentration of the products of bacterial fermentation, butyrate and 
acetate (Figure 6a). They hypothesized that this may occur because many of the 
members of the Firmicutes’ domain are butyrate producers, and that the microbiota found 
in obese mice contained a higher percentage of Firmicutes than did their lean littermates. 
 21 
 
They hypothesized that the obese gut microbiota was more efficient at extracting energy 
from the diet than the microbiota from a lean individual. They verified this hypothesis by 
using bomb calorimetry of the fecal gross energy content (kcal g
-1
) of 9 lean and 13 obese 
conventionally raised C57BL/6J mice. The results indicated that the fecal matter of the 
obese mice contained less energy than that of the lean mice (Figure 6b). The researchers 
also tested this by attempting to pass this trait on to lean individuals. The colonization of 
10 GF C57BL/6J mice with an obese (ob/ob) microbiota from 9 obese mice showed an 
increase of 47% body fat. In contrast, a GF C57BL/6J mouse colonized with microbiota 
from a lean +/+ donor showed an increase in 27% body fat over a period of 2 weeks. The 
body fat content was measured before and after a 14 day colonization using dual energy 
x-ray absorptiometry (Figure 6c). There was no change in caloric intake or food 
consumption (Turnbaugh et al., 2006). 
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Figure 6. Analysis of the ob/ob microbiome. (A) Gas-chromatography mass-
spectrometry quantification of short-chain fatty acids in the caeca of 4 lean and 5 obese 
conventionally raised C57BL/6J mice. (B) Results from bomb calorimetry of fecal gross 
energy content in 9 lean (+/+, ob/+) and 13 obese (ob/ob) conventionally raised 
C57BL/6J mice. This evidence suggests that the obese microbiome may be more efficient 
at extracting energy than the lean microbiome. (C) 10 GF mice wild type C57BL/6J mice 
were colonized with the caecal microbiota from 9 obese (ob/ob) donors resulting in 
greater total body fat content (Turnbaugh et al., 2006) 
 
There have only been a few studies examining the gut microbiota in human 
subjects. However, one of the first was performed by Ley and his colleagues in 2006. 
They sought to determine if the composition of the gut microbiota in obese individuals 
differed from that of lean individuals. They studied the microbiota in 12 obese men and 
women aged 21 to 65 years old over the course of one year. Their body mass index 
(BMI) ranged from 30 to 43 kg/m
2
. They assigned each subject to either a fat restricted 
diet (Fat-R) or a low calorie diet (Carb-R) with the goal to monitor how these diets 
affected the composition of their gut microbiota. The recommended caloric intake for 
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men was 1500-1800 kcal/day and 1200-1500 kcal/day for women. Four fecal samples 
were taken: one prior to the start of the study and three more at 12, 26 and 52 weeks after 
the onset of the diet therapy. Fecal samples were compared with samples from two 
healthy men, aged 32 and 36 who both had a BMI of 23 kg/m
2
. The microbiota was 
monitored by sequencing the 16s rRNA sequences from the volunteers’ stool samples. 
They found that 70% of the phylotypes were distinctive to each volunteer regardless of to 
which diet restricted group they were assigned. However, despite this interpersonal 
variation among the phylotypes, they found that 92.6% of all 16s rRNA sequences 
belonged to either the Firmicutes or Bacteroidetes phylum. Additionally, they found that 
obese individuals at the beginning of the study had more Firmicutes (P=0.002) and fewer 
Bacteroidetes (P<0.001) than did lean controls. Throughout the course of the study, the 
relative abundance of Firmicutes decreased (P=0.002) and the relative abundance of 
Bacteroidetes increased (P<0.001). These changes were seen irrespective of which diet 
the subject was placed on. These changes were seen throughout all species detected 
within the phyla and not due to blooms or extinctions of specific bacterial species. 
Another interesting finding was that the increased abundance of Bacteroidetes was 
correlated with the percentage of body weight lost and not with changes of dietary calorie 
content overtime (Figure 7) (Ley et al., 2006). However, this study is limited due to the 
small sample size of volunteers used.  
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Figure 7. Relative abundance of Firmicutes and Bacteroidetes seen 
throughout the experiment. (Ley et al., 2006). 
 
Duncan et al. did a study to determine the relationship between BMI, weight loss 
and major bacterial groups found in human subjects’ fecal samples during a 4 week diet 
(S H Duncan et al., 2008). Using 16s rRNA-based quantitative fluorescent in situ 
hybridization (FISH), the researchers monitored major bacterial groups in 18 obese male 
subjects. This data was later extended to include another 15 obese male subjects and 14 
unspecified, non-obese subjects. A subject was determined to be obese if their BMI was 
greater than or equal to 30kg/m
2
. A certain bacterial group was expressed relative to the 
total number of bacteria that was present in a subject’s fecal sample. This total number of 
bacteria was estimated using a broad probe (Eub338) which can detect nearly 73% of 
bacteria present by direct staining using 4,6-diamido-2-phenylindole. There were similar 
amounts of total number of bacteria between obese and non-obese subjects. They found 
that obese subjects had a total bacteria amount of 5.52 x 10
10
 cells/g feces and non-obese 
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subjects had 5.59 x 10
10
 cells/g of feces. The researchers measured the amount of 
Bacteroidetes using the Bac303 probe. There was no difference in the total amount of 
Bacteroidetes between obese and non-obese subjects consuming a weight maintaining 
diet (27.2 vs 21.9%, SED=2.96, P=0.084). Additionally, they did not find a significant 
relationship between BMI and the proportion of Bacteroidetes (correlation 0.13, P=0.40) 
(Figure 8). 23 obese subjects were then placed on two weight loss diets for 8 weeks: a 
high-protein low carbohydrate, ketogenic diet or a high-protein moderate-carbohydrate, 
non-ketogenic diet. Each subject spent 4 weeks on one diet. The researchers did not 
identify a difference in the ratio of Firmicutes and Bacteroidetes between the non-obese 
and obese individuals at the end of the study. Additionally using the Bac303 probe, they 
did not find an increase in members of the Bacteroidetes phylum throughout the weight 
loss (R2: 0.08, P=0.11). However, they did find that the abundance of 2 specific groups 
of bacteria within the Firmicutes’ phyla, Roseburia spp. and Eubacterium rectale, both 
decreased with decreased carbohydrate intake. Interestingly, they found that fecal 
butyrate concentration decreased, a finding consistent with Turnbaugh et al. However, 
conclusions from this study may be limited because the study was performed only for 4 
weeks and had a relatively small sample size.  
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Figure 8. Relationship between percentage of Bacteroidetes in fecal matter 
compared to BMI (S H Duncan et al., 2008). 
 
In 2007, researchers sought to further clarify why GF mice, fed the same diet as 
conventional mice, failed to develop obesity. Conventional mice and GF C57BL/6J mice 
were fed a high-fat, sugar-rich “western” diet. They found prior to conventionalization, 
that there is a change in the composition of the gut microbiota in genetically obese 
(ob/ob) mice such that there was a 50% decrease in Bacteroidetes and a corresponding 
increase in the percentage of Firmicutes when compared to the microbiota of their lean 
(+/+ and ob/+) littermates. Additionally, metagenomic analyses of the microbes that 
resided in the distal gut microbiota of obese mice, fed a standard low-fat rodent chow, 
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revealed that the microbiota was enriched with genes that were able to extract calories 
from complex plant-derived polysaccharides. Additionally, GF +/+ mice that were fed a 
standard low-fat, high polysaccharide rodent chow were conventionalized with the 
microbiota from either obese ob/ob mice or from their lean littermates (+/+ and ob/+).  
They found that the GF mice that were conventionalized with the microbiota from obese 
mice had a higher incidence of adiposity over a 2 week period than the GF mice that were 
conventionalized with the gut microbiota from their lean littermates (Backhed, 
Manchester, Semenkovich, & Gordon, 2007).  
 
Figure 9. Change in body weight seen in Conventionalized Western and GF Western 
mice over the course of 8 weeks (Backhed et al., 2007). 
 
In 2008, Turnbaugh and colleagues continued to investigate the relationship that 
the gut microbiota may have in the development of obesity. They explored the 
relationship between diet, gut microbial ecology and energy balance in an obese mouse 
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model consuming a prototypical “western” diet. Ten GF C57BL/6J mice were fed a low-
fat, carbohydrate rich rodent chow. At 12 weeks of age, these mice were gavaged with 
the caecal microbiota from a conventionally raised mouse. Four weeks after the 
conventionalization, 5 of the GF mice were then switched to a diet that a ‘Western’ diet 
that was high in both saturated and unsaturated fats. 41% of calories in this diet came 
from these fats. The other 5 mice remained on the carbohydrate rich diet. Twelve weeks 
after the conventionalization, the researchers noted that the mice on the ‘Western’ diet 
gained considerably more weight (5.3±0.8g versus 1.5±0.2g; p<0.05 ) than did the mice 
consuming the carbohydrate chow. The caecal contents were then examined. 16s rRNA 
gene sequence based surveys and UniFrac- based analysis were performed on the caecal 
contents of these ten mice along with the caecal contents of the conventionally raised 
donor mouse. They found that diet induced obesity (DIO) produced a bloom of bacteria 
within a specific class of Firmicutes, the Mollicutes. This class is normally present at a 
smaller percentage of the gut microbiota in the distal intestine, however, during diet 
induced obesity, it became a dominant member (Figure 10). They stated that this bloom 
was associated with an increase in fitness for this particular class of bacteria compared to 
other bacteria in the Firmicutes phyla as well as members of the Bacteroidetes phyla. 
Interestingly, when the diet was manipulated to limit weight gain and reduce adiposity, 
this bloom was diminished. When they studied this class of bacteria in further detail, they 
found that the Mollicutes class had evolved the ability to import and metabolize certain 
types of carbohydrates that were commonly present in Western diets, such as glucose, 
fructose and sucrose. The products of this bacterial metabolism were SCFA’s that the 
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host was able to utilize. They confirmed results from previous experiments when they 
showed that when the microbiota from diet induced obese mice was transplanted into GF 
mice, it produced a greater increase in adiposity than when the microbiota from lean 
donors into GF mice. Additionally, there was an increased adiposity in GF mice seen 
when transplantation of microbiota from mice who were consuming a “western” style 
diet than from mice that were consuming a carbohydrate rich diet. The GF mice were fed 
a low-fat polysaccharide-rich carbohydrate diet (Turnbaugh, Backhed, Fulton, & Gordon, 
2008). 
 
 
Figure 10. Changes seen in the gut microbiota with diet induced obesity. Black boxes 
indicate nodes that were reproduced in >70% of all jackknife replications Pie charts 
reveal the average relative abundance of bacterial lineages in the two different diets. 
(Turnbaugh et al., 2008) 
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In 2010 Fleissner and colleagues’ results conflicted with previous findings that 
GF mice were resistant to diet induced obesity. GF mice were fed with three different 
diets: a low fat diet, a high fat diet and a “western diet”. They found that when GF mice 
were fed a low-sucrose, lard-based high fat diet, the GF mice became obese. Intriguingly 
however, when these mice consumed a high sucrose, high palm oil “western” diet, the GF 
mice were resistant to obesity. The authors also found that with the mice on the high fat 
diet and western diet, the relative amount of Firmicutes increased and the amount of 
Bacteroidetes decreased. This study did use a different strain of GF mice, the C3H strain 
(Fleissner et al., 2010).  
In 2011, Jumpertz and colleagues set out to find how the gut microbiota affected 
nutrient metabolism in humans. Bäckhed and colleagues in 2004 postulated that the gut 
microbiota had been able to alter nutrient absorption by modulating the expression of 
lipoprotein lipase inhibitor in mice. However, it had not been studied whether the gut 
microbiota had this same effect in humans. Jumpertz and colleagues set out to monitor 
the variations of the gut microbiota during caloric consumption that ranged from 
2400kcal/day to 3400kcal/day. These changes were observed by pyrosequencing bacterial 
16S rRNA genes present in the stool samples provided by twelve lean and nine obese 
individuals. Ingested calories were measured through bomb calorimetry. They found that 
when their subject ingested more calories, there was a swift change in the subject’s gut 
microbiota. It was seen that in lean individuals, a twenty percent increase in the 
Firmicutes’ population and a corresponding decrease in Bacteroidetes was associated 
with increased energy loss in the subject’s stool of about 150kcal. However, there was no 
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change seen in the weight maintaining diet that researchers initially placed the subjects 
on (Jumpertz et al., 2011). As was the case with the other human trials, this study did 
have a small sample size.  
 
 
Figure 11. Associations between the Bacteroidetes and the Firmicutes in the distal 
gut. Graphs A and B represent the 2400kcal/d diet. Graphs C and D represent the 3400 
kcal/d diet. These graphs show the associations between the changes in relative number 
of Firmicutes and Bacteroidetes in the weight maintaining diet (WMD) and  as a 
percentage of weight maintaining needs (%WMEN) (Jumpertz et al., 2011) 
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Zhang and colleagues set out to solve the discrepancy between previous results of 
papers that either did find a difference in the ratio of Firmicutes and Bacteroidetes or did 
not. A group of adult C57BL/6J mice consumed a high fat diet for 12 weeks. Throughout 
the experiment, the microbiota from the diet induced obese (DIO) mice was compared to 
lean mice that were fed a diet rich in carbohydrates. These mice displayed significant 
levels of newly acquired obesity and insulin resistance. The researchers subsequently 
placed the mice on a normal fat diet for 10 weeks. Researchers observed a relative 
increase in the amount of Firmicutes and a decrease in the amount of Bacteroidetes in the 
DIO mice that were fed a high fat diet for 12 weeks. Additionally, they found that the 
relative abundance of a third phylum, Proteobacteria, increased while the mice were 
consuming the high fat diet. The researchers then sought to see if these changes were 
reversible if the mice reverted to being fed a normal fat diet. They placed the DIO mice 
on a normal chow diet for 10 weeks. After 4 weeks on this diet, the previous changes that 
were seen in the microbiota when the mice consumed a high fat diet, reverted to a 
composition similar to that of the mice consuming the diet rich in carbohydrates. The 
researchers performed a redundancy analysis on the fecal matter of the DIO mice and 
isolated 77 key phylotypes that responded to the alterations in the diets (Zhang et al., 
2012).  
Recently, Fei and Zhao sought to see what the ramifications of a long term high 
fat diet on GF mice were. They fed mice a non-western high fat diet. After the first 8 
weeks, they noted that the GF mice gained a substantial amount of body weight (Figure 
12). However, after this initial period the mice began to lose weight. After 17 weeks, the 
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body weight of the mice was no different than the mice that they were being compared to 
being fed normal rodent chow (Fei & Zhao, 2013). 
 
 
Figure 12. Initial weight changes in body weight and fat pad weight between 4 
strains of mice (Fei & Zhao, 2013). 
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DISCUSSION 
 
  The results presented here indicate that the gut microbiota has a role in weight 
regulation and that it can be altered through diet or microbiota transplantation in GF 
mice. They also indicate the ratio of Firmicutes to Bacteroidetes may vary in obese 
individuals and mice, and that this ratio may be associated with obesity.  However, the 
results from different studies vary regarding whether Bacteroidetes or an increased ratio 
of Firmicutes vs. Bacteroidetes, or vice versa, correlates with the development of obesity.  
 The first studies to examine the gut microbiota identified a difference in the ratio 
of Firmicutes to Bacteroidetes in obese and non-obese mice. They hypothesized that 
these differences in the composition of the gut microbiota may have contributed to the 
development of obesity(Bäckhed et al., 2004; Ley et al., 2005; Turnbaugh et al., 2006). 
As mentioned above, Ley et al re-examined these findings and again identified a 
difference in the ratio of Firmicutes to Bacteroidetes between obese and non-obese 
subjects. They concluded that obesity has an effect on the composition of the gut 
microbiota and suggested that their results may lead to findings where the manipulation 
of the composition of the gut microbiota may be useful in helping combat obesity in 
individuals. That same year, Turnbaugh and colleagues found that the caecum of obese 
mice contained an increased concentration of butyrate and acetate as well as noting that 
the microbiota of obese mice had had a higher concentration of Firmicutes. They 
determined that this was consistent with the fact that many of the members of the 
Firmicutes’ domain were butyrate producers. They suggested that their findings 
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reinforced the perception that the gut microbiota should be viewed as a possible 
contributor, along with host genotype and lifestyle, to the development of obesity and its 
associated disorders. These papers were the first to indicate that the gut microbiota may 
have a role in weight regulation in mice. They were also the first to identify the 
difference in ratio of Firmicutes to Bacteroidetes, which led to future studies examining 
this concept.  
 Ley’s findings in human subjects in 2006 indicated that, like in the gut microbiota 
of mice, a change in the composition of the gut microbiota in humans through dietary 
alterations is possible. They also found that obese individuals had a higher ratio of 
Firmicutes to Bacteroidetes, which was consistent with their previous findings in obese 
and non-obese mice. This study was one of the first to indicate that the gut microbiota 
may have a role in weight regulation in humans. Although Duncan and colleagues’ 
results in humans did not show a change in the ratio of Firmicutes to Bacteroidetes, they 
did find that two SCFA producing members, Roseburia spp. and Eubacterium rectale, 
did decrease with decreased carbohydrate intake. They suggested that their findings 
indicated that the composition of the gut microbiota is capable of being altered through 
diet. Secondly, they argued that their results illustrate that microbes living in the colon 
may have specific niches that vary depending on the host’s diet and conditions of the 
human gut. Their findings demonstrate the importance that future research focus on 
examining the gut microbiota of both mice and humans at a more specific level than at 
the phyla level. The conflicting findings regarding the changes seen in the ratio between 
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Firmicutes and Bacteroidetes may be due to differences in the bacterial species that were 
detected in the various studies.  
In 2007, Bäckhed and colleagues found an increase in the Firmicutes to 
Bacteroidetes ratio in obese mice versus their lean counterparts. They also found that the 
obese microbiota was better able to extract calories form plant saccharides than their lean 
counterparts’ microbiota. They proposed that the gut microbiota has the ability to affect 
both the way that the host is able to extract calories from the diet as well as affect gene 
expression of genes that are involved in host energy expenditure and storage. Turnbaugh 
(2008) also wanted to study the relationship between the gut microbiota and energy 
balance. They found a bloom in a class of bacteria within the Firmicutes’ phylum, the 
Mollicute class, which was associated with diet induced obesity. They stated that their 
findings suggested that the Mollicute-enriched community enable the host to utilize 
calories in their diet as well as having an effect on the host metabolism of the absorbed 
calories. 
Fleissner’s study (2010) was also interesting because it was one of the first to 
show that GF mice are not resistant to diet-induced obesity (DIO) with all diets. Although 
this study used a different strain of GF mice than previous studies, the C3H strain, the 
researchers used their data to assert that the absence of a microbiota does not protect 
against obesity. They found that GF mice that were fed a low-sucrose, lard based high fat 
diet, became obese. However, in accordance with previous results, they also observed 
that GF mice were resistant to a high sucrose, high palm oil ‘western’ diet. Therefore, 
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they postulated that diet affects the composition of the microbiota more than previously 
thought (Fleissner et al., 2010). Although these results are not consistent with some of the 
previous findings, they indicate that the gut microbiota is an essential component to the 
development of DIO in mice and that it could possibly have a causative role in the 
development of obesity in humans (Zhao, 2013). 
Also presented in this paper are opposing results seen in recent studies regarding 
possible differences in the ratio between the Firmicutes and the Bacteroidetes in obese 
and non-obese individuals. While some studies have shown that there is a difference in 
the ratio of Firmicutes to Bacteroidetes between obese and non-obese individuals (Ley et 
al., 2006; Turnbaugh et al., 2006), other studies performed have shown that there is no 
difference in this ratio (S H Duncan et al., 2008; Schwiertz et al., 2010). Researchers 
hypothesized that the reason for the conflicting results may be because the changes seen 
in the microbiota between these individuals did not occur at the division level, but 
occurred at the phylotype level (Filippo et al., 2010; Zhang et al., 2010). However, this 
may be a limitation of all of the studies presented here. Due to the vast number of 
bacterial species living within the human gut microbiota, the variation in the gut 
microbiota between individuals and the changes seen in the microbiota throughout an 
individual’s life, it is not possible to identify and monitor all of the species of the human 
gut microbiota with the current technology (Lozupone et al., 2012). 
Zhang and colleagues (2012) sought to resolve the controversy behind the 
Firmicutes/Bacteroidetes (F/B) ratio. They found that there was an increase in the 
 38 
 
amount of Firmicutes after the mice were placed on a high fat diet, and that this change 
was quickly reversible. They concluded that when mice consume a diet high in fat, it 
caused increases or decreases in the number of specific phylotypes that were present in 
the gut microbiota. Secondly, their results showed that the gut microbiota in mice is 
adaptable and capable of responding to the perturbations of the diet. 
Jumpertz et al found that when obese and lean human subjects were placed on an 
initial weight maintaining diet, an increased F/B ratio was not seen in obese versus lean 
individuals. However, they did find that when subjects ingested more calories, there were 
swift corresponding changes within the gut microbiota. They stated that when lean 
individuals overfed on either the 2400kcal/day diet or the 3400kcal/day diet, there was a 
decrease in the amount of energy lost in a subject’s stool. The researchers suggested that 
this study produced two important ideas regarding the gut microbiota. First, the 
composition of the microbiota can be quickly altered based on how many calories a 
person ingests. Second, the gut microbiota could play a valuable role in the nutrient 
harvest. These results again indicate that the gut microbiota has a role in weight 
regulation in humans, even though the mechanism has yet to be clarified.  
Researchers have proposed many different mechanisms for how this may be 
possible. One hypothesis is that a bloom of endotoxin producers in the colon contributes 
to additional weight gain in the host. Lipopolysaccharide (LPS) is a molecule made up of 
both a lipid component and a polysaccharide component that is found in the outer 
membrane of Gram-negative bacteria. It has been shown that when injected into a host, it 
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provokes an immune response. Researchers have used LPS as a model endotoxin to study 
the effects of bacteria in the colon. In 2007, P. Cani and colleagues performed a low-rate 
infusion of LPS into mice. They induced metabolic endotoxemia through the 
subcutaneous injection of LPS (300μg kg-1day-1) in 12 week old C57BL/6J mice using an 
implanted osmotic mini-pump for 4 weeks. The results were compared to mice that had 
the same implanted osmotic mini-pump which was injecting a 0.9% sodium chloride 
solution as well as to mice that were fed a 72% high fat diet without an implanted LPS 
infusion mini-pump. The mice with the LPS and saline infusion mini-pumps were fed a 
normal fat diet. The infusion of LPS provoked a systemic inflammation, similar to the 
chronic low grade inflammation that is seen in obesity, in the mice. The mice 
subsequently displayed many characteristics of metabolic syndrome such as obesity and 
insulin resistance. They hypothesized that the infusion of LPS was able to increase gut 
permeability leading to increased bacterial endotoxemia. This subsequent endotoxemia 
lead to low grade inflammation, like what is seen in obesity, and eventually to 
characteristics of metabolic syndrome (Cani et al., 2007).   
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CONCLUSION 
 
 Obesity has had a dramatic increase in the past fifty years. This could be due to 
many factors, but diet and lifestyle choices are thought to be the most likely causes. An 
increased caloric intake combined with a decreased caloric expenditure, as has become 
more common in developed countries, has caused many people to become overweight. 
Although this may be the primary cause of weight gain, recent research presented here 
indicates that the gut microbiota has a role in weight regulation in the human host. The 
mechanism by which the gut microbiota is able to accomplish this is still being 
elucidated. However, these studies show that a dysbiosis of the gut microbiota negatively 
affects how the host regulates energy balance and expenditure. They indicate that the gut 
microbiota has role in weight regulation that was not previously known.  
 There have been contradictory results concerning a possible change in the ratio of 
Firmicutes to Bacteroidetes in obese and non-obese mice and individuals. Many studies 
found a difference in the ratio between Firmicutes and Bacteroidetes between obese and 
non-obese individuals. However, other studies found no difference in this ratio. In 2008, 
the results from Gordon et al showed that there is an increase in a specific taxon of 
Firmicutes, the Mollicutes class. This finding indicates that research solely focusing on 
changes at the phyla level may not be specific enough to show what is occurring at lower 
taxon levels. For instance, their results show that changes in diet was associated with 
changes in one class of Firmicutes. The studies performed by Duncan et al and Ley et al 
also show the contradiction in findings regarding the F/B ratio in humans. These studies 
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suggest that the gut microbiota may have to be monitored at a more specific level than the 
phylum if researchers seek to determine how the composition of the microbiota affects 
health and energy expenditure. However, the findings suggest that a dysbiosis in the 
composition of the gut microbiota is associated with weight gain and obesity 
development.  
 Another interesting aspect of these studies is that they demonstrate that the gut 
microbiota is capable of being altered either through diet or conventionalization. This is 
an important finding because it could lead to interventions in the future to combat obesity 
and aspects of metabolic syndrome.   
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FUTURE DIRECTIONS 
 
 The study of the intestinal microbiota is an important endeavor due to its 
importance in human health. It has been shown that the dysbiosis of these microbes may 
lead to obesity and other health complications. The understanding of how exactly the gut 
microbiota affects human health will require further studies. With this information, 
medical professionals and the general public will be able to use this knowledge to achieve 
better health and possibly alleviate one of the causes of weight gain. 
 The core features of the gut microbiota should be a topic of study that is first 
clarified. Examples of these features could be specific species of bacteria and the 
compositions of those bacteria that provide the host with the most benefits. If features of 
the gut microbiota are known, it will provide the opportunity to manipulate the gut 
microbiota from a state of dysbiosis to a state that resembles a more ‘healthy’ gut 
microbiota. It will also provide the opportunity to learn what promotes the health of 
desired species and what can be done to exclude the undesirable species. Although 
researchers have found certain similarities between individuals, identifying the core 
features will be difficult at first due to the complex nature of the gut microbiota and the 
variation between individuals (Lozupone et al., 2012). Additionally, without more 
detailed information regarding the core features of the microbiota, it is difficult to assess 
how different dietary substrates influence individual taxa, how taxa cooperate or compete 
within the intestine for nutrients and how the collection of these taxa lead to host 
phenotypes (McNulty et al., 2013). Currently, there are a few projects that are attempting 
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to decipher the core features of the human gut microbiota. They include the European 
Metagenomics of the Human Intestinal Tract and the US Human Microbiome Project 
(National Institutes of Health, 2014). 
 A greater understanding of the gut microbiota could also lead to advances in 
medicine and treatments and well as personalized diets. For instance in 2012, Vrieze et al 
found that the insulin sensitivity of male human subjects with a history of metabolic 
syndrome increased after they were given small intestinal infusions of allogenic or 
autologous microbiota from lean healthy donors. These findings lead the researchers to 
suggest that the gut microbiota may be a therapeutic target for insulin resistance in the 
future (Vrieze et al., 2012). Additionally, as shown throughout this paper, the gut 
microbiota may be a target for weight regulation.  
 Another topic of study would be the effects, benefits and disadvantages of 
probiotics and prebiotics. It has been shown that a decreased diversity in the gut 
microbiota can lead to many gastrointestinal and extraintestinal disorders. One such 
disorder, irritable bowel syndrome, has been associated with a reduction of specific 
organisms that leads to a higher risk of developing this disorder (Shanahan et al., 2012). 
Therefore, probiotics and prebiotics, either used separately or in combination, could help 
people achieve a more healthy gut microbiota by providing the opportunity to replenish 
certain beneficial bacterial species or possibly alter the composition of the gut microbiota 
back to a more ‘healthy state’. 
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Lastly, it will be worthwhile to study the effectiveness of bacteriotherapy in 
helping the gut microbiota revert into a healthy state. Fecal bacteriotherapy, or fecal 
transplant, has been shown to be effective at altering the gut microbiota. Additionally, it 
has been shown recently to be an effective treatment in treating recurrent Clostridium 
difficile-associated diarrhea (CDAD) in humans. Mortality rates due to Clostridium 
difficile infections have increased in the United States recently (Redelings, Sorvillo, & 
Mascola, 2007) (Figure 13). Fecal transplant introduces a fecal preparation from a 
healthy donor as a homogenate by injection into the caecum using a colonoscope. In a 
recent study involving 317 patients suffering from CDAD across 27 case series, fecal 
transplant had a 92% success rate at disease resolution (Gough, Shaikh, & Manges, 
2011). In fact, 89% of the cases of CDAD were resolved after the first fecal transplant. In 
one particular case, researchers found that one month after the procedure, C. difficile was 
not present in a patient’s stool sample after previously being affected with CDAD. 
Additionally, species from the donor were present in the stool sample which suggests that 
donor’s microbiota possessed the capability to persist in the recipient’s caecum during 
this interval (Lozupone et al., 2012). Fecal transplant could have many possible roles in 
the future. It could be used to promote or establish a healthy colony of microbes in the 
colon, treat intestinal infections without the use of antibiotics and could be used as a 
possible treatment for one of the causes of obesity. 
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Figure 13. Yearly rates of Clostridium difficile-related mortality rates per million 
population in the United States between 1999 and 2004 (Redelings et al., 2007). 
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